Article Research Portal

Structured Abstract

Background: Hemorrhoids (Arsha) present significant global morbidity. Classical Ayurvedic literature highlights Triphala Churna for its vatanulomana, deepana, and vrana ropana efficacy.

Methods: A prospective, open-label clinical trial was conducted on 60 patients with diagnosed Grade I and II internal hemorrhoids over an eight-week duration. Objective parameters included reduction in bleeding per rectum, pain score on visual analog scale (VAS), and mucosal prolapse grade.

Results: Statistically significant symptom remission was achieved in 88.3% of participants (p < 0.001). Bleeding per rectum ceased completely in 76.6% within 14 days without adverse clinical reactions.

Conclusion: Standardized Triphala Churna is a safe, reproducible, cost-effective first-line conservative intervention for early-stage internal hemorrhoids.

Introduction & Methodology

Ayurveda conceptualizes hemorrhoids as Arsha, stemming from impaired digestive fire (Mandagni) and vitiated Apana Vayu. In modern proctology, internal hemorrhoidal disease remains a predominant cause of rectal bleeding and discomfort.

Dosage and Administration

Participants were administered 5 grams of standardized Triphala Churna twice daily with warm water after principal meals for 8 consecutive weeks, accompanied by standard dietary fiber intake guidance.

Cited Literature & References

1. Sushruta. Sushruta Samhita, Chikitsa Sthana, Chapter 6: Arsha Chikitsa. Varanasi: Chaukhambha Orientalia; 2018:p. 45-52.
2. Peterson CT, Denniston K, Chopra D. Therapeutic uses of Triphala in Ayurvedic medicine. J Altern Complement Med. 2017;23(8):607-614. doi:10.1089/acm.2017.0083.
3. Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-2017. doi:10.3748/wjg.v18.i17.2009.
4. Charaka. Charaka Samhita, Chikitsa Sthana, Chapter 14. Varanasi: Chaukhambha Sanskrit Sansthan; 2016:p. 210-218.